Lanean...
CFTR Modulator Therapies in Pediatric Cystic Fibrosis: Focus on Ivacaftor
INTRODUCTION: Mutations in the cystic fibrosis transmembrane conductance regulator protein (CFTR) cause cystic fibrosis (CF), a disease with life threatening pulmonary and gastrointestinal manifestations. Recent breakthrough therapies restore function to select disease-causing CFTR mutations. Ivacaf...
Gorde:
| Argitaratua izan da: | Expert Opin Orphan Drugs |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5193376/ https://ncbi.nlm.nih.gov/pubmed/28042521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2016.1226800 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|